位置:首页 > 蛋白库 > NR3BA_DANRE
NR3BA_DANRE
ID   NR3BA_DANRE             Reviewed;        1686 AA.
AC   A1XQY1; A1XQY2;
DT   21-SEP-2011, integrated into UniProtKB/Swiss-Prot.
DT   06-FEB-2007, sequence version 1.
DT   03-AUG-2022, entry version 85.
DE   RecName: Full=Neurexin-3b;
DE   AltName: Full=Neurexin IIIb-alpha;
DE   AltName: Full=Neurexin-3b-alpha;
DE   Flags: Precursor;
GN   Name=nrxn3b;
OS   Danio rerio (Zebrafish) (Brachydanio rerio).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Actinopterygii; Neopterygii; Teleostei; Ostariophysi; Cypriniformes;
OC   Danionidae; Danioninae; Danio.
OX   NCBI_TaxID=7955;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A AND 2A), DEVELOPMENTAL STAGE, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=17041151; DOI=10.1093/molbev/msl147;
RA   Rissone A., Monopoli M., Beltrame M., Bussolino F., Cotelli F., Arese M.;
RT   "Comparative genome analysis of the neurexin gene family in Danio rerio:
RT   insights into their functions and evolution.";
RL   Mol. Biol. Evol. 24:236-252(2007).
CC   -!- FUNCTION: Neuronal cell surface protein that may be involved in cell
CC       recognition and cell adhesion.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC       membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=3;
CC         Comment=A number of isoforms, alpha-type and beta-type are produced
CC         by alternative promoter usage. Beta-type isoforms differ from
CC         alpha-type isoforms in their N-terminus.;
CC       Name=1a;
CC         IsoId=A1XQY1-1; Sequence=Displayed;
CC       Name=2a; Synonyms=Soluble form;
CC         IsoId=A1XQY1-2; Sequence=VSP_041708, VSP_041709;
CC       Name=1b;
CC         IsoId=A1XQY3-1; Sequence=External;
CC   -!- DEVELOPMENTAL STAGE: After the very early developmental stages, the
CC       expression levels decrease and remain relatively constant until around
CC       24 h, with the onset of an increase of expression that continues till
CC       the larval stages. {ECO:0000269|PubMed:17041151}.
CC   -!- MISCELLANEOUS: [Isoform 2a]: Produced by alternative splicing.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the neurexin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ641435; ABG25172.1; -; mRNA.
DR   EMBL; DQ641436; ABG25173.1; -; mRNA.
DR   RefSeq; NP_001073516.1; NM_001080047.1.
DR   AlphaFoldDB; A1XQY1; -.
DR   SMR; A1XQY1; -.
DR   STRING; 7955.ENSDARP00000107689; -.
DR   PaxDb; A1XQY1; -.
DR   GeneID; 570698; -.
DR   KEGG; dre:570698; -.
DR   CTD; 570698; -.
DR   ZFIN; ZDB-GENE-070206-10; nrxn3b.
DR   eggNOG; KOG3514; Eukaryota.
DR   InParanoid; A1XQY1; -.
DR   OrthoDB; 35129at2759; -.
DR   PhylomeDB; A1XQY1; -.
DR   ChiTaRS; nrxn3b; zebrafish.
DR   Proteomes; UP000000437; Genome assembly.
DR   Proteomes; UP000814640; Unplaced.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   CDD; cd00110; LamG; 6.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR003585; Neurexin-like.
DR   InterPro; IPR027789; Syndecan/Neurexin_dom.
DR   Pfam; PF02210; Laminin_G_2; 6.
DR   Pfam; PF01034; Syndecan; 1.
DR   SMART; SM00294; 4.1m; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00282; LamG; 6.
DR   SUPFAM; SSF49899; SSF49899; 6.
DR   PROSITE; PS50026; EGF_3; 3.
DR   PROSITE; PS50025; LAM_G_DOMAIN; 6.
PE   2: Evidence at transcript level;
KW   Alternative promoter usage; Alternative splicing; Angiogenesis; Calcium;
KW   Cell adhesion; Disulfide bond; EGF-like domain; Membrane; Metal-binding;
KW   Reference proteome; Repeat; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..1686
FT                   /note="Neurexin-3b"
FT                   /id="PRO_0000412553"
FT   TOPO_DOM        24..1610
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1611..1631
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1632..1686
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          24..198
FT                   /note="Laminin G-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          194..231
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          254..451
FT                   /note="Laminin G-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          458..650
FT                   /note="Laminin G-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          654..691
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          696..859
FT                   /note="Laminin G-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          876..1048
FT                   /note="Laminin G-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   DOMAIN          1051..1088
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          1092..1292
FT                   /note="Laminin G-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00122"
FT   REGION          1324..1348
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1501..1545
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1653..1686
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1653..1668
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1669..1686
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         300
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         317
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   BINDING         380
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250"
FT   DISULFID        198..209
FT                   /evidence="ECO:0000250"
FT   DISULFID        203..218
FT                   /evidence="ECO:0000250"
FT   DISULFID        220..230
FT                   /evidence="ECO:0000250"
FT   DISULFID        415..451
FT                   /evidence="ECO:0000250"
FT   DISULFID        621..650
FT                   /evidence="ECO:0000250"
FT   DISULFID        658..669
FT                   /evidence="ECO:0000250"
FT   DISULFID        663..678
FT                   /evidence="ECO:0000250"
FT   DISULFID        680..690
FT                   /evidence="ECO:0000250"
FT   DISULFID        1020..1048
FT                   /evidence="ECO:0000250"
FT   DISULFID        1055..1066
FT                   /evidence="ECO:0000250"
FT   DISULFID        1060..1075
FT                   /evidence="ECO:0000250"
FT   DISULFID        1077..1087
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1368..1403
FT                   /note="GGELVIPVLVEDPIDIPPISTRVPFIPLPPTLHPVL -> AQSSFATRTLRT
FT                   ALTWTWQLMYTFTSIYFISYLVCS (in isoform 2a)"
FT                   /evidence="ECO:0000303|PubMed:17041151"
FT                   /id="VSP_041708"
FT   VAR_SEQ         1404..1686
FT                   /note="Missing (in isoform 2a)"
FT                   /evidence="ECO:0000303|PubMed:17041151"
FT                   /id="VSP_041709"
FT   CONFLICT        1013
FT                   /note="P -> S (in Ref. 1; ABG25173)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1686 AA;  185768 MW;  5A273F4741B68073 CRC64;
     MPPHCQPHCV LLLLSTFLSL GLGLEFTGSE GQWARYLRWD ASTRSDLSFQ FKTAISDALV
     LYFDDGGYCD FLLLSIEDAK LKLRFSVDCA ETTITSDKMV NDSHWHFATI SRHNLRTVLA
     LDGDSKVDEV RPQRQFMKIV SDLYLGGVPQ DIRTSALTLP AAKEMPPFKG IITDLGYGNK
     VPTRLGSQKV RLEMEGFCTE NPCENGGSCS MADGEAYCDC SKTGYTGRYC NEAVNKTPGF
     AHMVKSPQAR EENVATFRGS EYFCYDLSQN PIQSSSDEIT LSFKTWQRNG LILHTGKSAD
     YVNLALKDGA VSLVINLGSG AFEAIVEPVN GKFNDNAWHD IKVTRNLRQH SGIGHAMVNK
     LHCLVTISVD GILTTTGYTQ EDYTMLGSDD FFYVGGSPST ADLPGSPVSN NFMGCLKEVV
     YKNNDIRLEL SRLARIADPK MKLQGDIVFK CENVPTLDPI SFETAESFLG LPKWNTKRVG
     SISFDFRTSE PNGLILFTQG KPQDKKDSRS QRSNKVDFFA VELLDGHLYL LLDMGSGTIK
     VKATQNKVND GVWHHVDIQR DGRSGIISVN SRRTPFTASG ENEILDLEGN LYLGGLPDNR
     ADLILPTELW TAMLNYGYVG CIRDLFIDGR SKDIRQIAEA QNVGGIKSSC SKVTAKQCDS
     NSCKNNGICK EGWNRFICDC TGTGYWDRTC EREASILSYD GSMYMKVVMP TIIHTEAEDV
     SLRFMSQRAF GLLMAATSRE SADTLRLELD SGRVKLIVNL GKGPETLYAG QKVNDNDWHS
     VRVTRRGKNI KLMVDDDVAE GQMNGDHTRL EFSNVETGIL TERRFASTAP SNFIGHLQGL
     KFNGLLYIDM CKNGDIEFCE LNARFGMRSI VADPVTFKTK GSYLGLATLQ AYSTMHLFFQ
     FKTTSGDGFI LFNSGDGNDF IAVELVKGYI HYVFNLGNGP SLLKGNSDSP LNDNQWHNVV
     ITRDASNTHT LKVDAKSVSQ VVNGAKNLDL KGDLFVAGLG PNMYQNLPKL VVPREGFQGC
     LASMDLNGRL PDLINDALFR SGQIERGCEG PSTTCQEDSC ANMGVCIQQW ENFTCDCSMT
     SYSGTQCNDP GATYIFGKGG GLIMYTWPNN ERPSTRTDRL AVGFSTTIKD GILVRIDSAP
     RLGDYIMLHI EEGKVCVTFN IGTVDISVKE MTTEVNDGKY HVVRFTRNGG NATLQVDNWP
     INEHFPSGNS DIERFQMANK KIPFKYTRPV EDWLHEKDRQ LTIFNTQATI SIGGNDRKRP
     YQGQLSGLYY NGLKVLNMAA EGHTNIKING SVRLVGDVPT SRSPSRTTTS MPPEMSTTFI
     ETTTTLSTTT TRKQRSPPTI QTTDDIVSSA ECSSDDEDLE ECDGGHTGGE LVIPVLVEDP
     IDIPPISTRV PFIPLPPTLH PVLTIIETTK ESLSIATEAG VPCFSDQGRD DCDDDDGDDD
     DGDGLVISGF GSGEVFDSSL PPTDDEDFYT TFSLVTDKIL TTSTYEGGYK ALAPKWEEKD
     FKPKKPSEVG RITAIPPLPD LRSSAASPVR PEPAPKIPAG KMNNREVKPQ PDIVLLPLPT
     SFDMDGTKPK GPYITQPMLR TIPSALPTVP GIRRVPPGAS EVIRESSSTT GMVVGIVSAA
     ALCILILLYA MYKYRNRDEG SYQVDETRNY ISNSAQNNGT VVKDKQPSTK GASNKRPKDK
     DKEYYV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024